High expression of CD47 predicts adverse prognosis in Chinese patients and suppresses immune response in melanoma

被引:21
|
作者
Fu, Wenhua [1 ]
Li, Jisen [1 ]
Zhang, Wei [1 ]
Li, Peng [1 ]
机构
[1] Peoples Hosp Weifang, Dept Cosmet & Plast Surg, 151 Guangwen St, Weifang, Shandong, Peoples R China
关键词
CD47; Melanoma; Prognosis; Survival; Immune response; CANCER; IMMUNOTHERAPY; DESTRUCTION; INHIBITION; TARGET; TUMORS; CELLS; BRAF;
D O I
10.1016/j.biopha.2017.06.030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Cluster of differentiation 47 (CD47) negatively regulates macrophage phagocytosis and is correlated with adverse survival of multiple cancers. In melanoma patients, especially in Chinese melanoma patients, its prognostic value is unclear. In this study, we aim to study the prognostic value of CD47 in a Chinse melanoma patient cohort and its immunomodulation roles in mouse model. Method: 164 melanoma tissue specimens were collected. The expression of CD47 in these clinical samples was examined by immunohistochemistry staining (IHC). The correlation between CD47 expression and clinicopathological parameters was assessed by statistical analysis. Prognostic values CD47 expression were also investigated. In an animal model, effects of CD47 expression on immune infiltration were examined. Results: CD47 expression was positively correlated with TNM stage, distant metastasis, and death of melanoma patients with the P value of 0.008, 0.018, and 0.032 respectively. High expression of CD47 was an independent prognostic marker of overall survival (HR = 1.563, 95% CI: 1.069-2.285) and progression free survival (HR = 1.542, 95% CI: 1.053-2.258) of Chinese melanoma patients. Conclusion: In conclusion, high expression of CD47 predicted poor survival in a Chinese melanoma patient cohort and impaired antitumor immune response in the animal model. Targeting CD47 might be a novel option for melanoma patients. (C) 2017 Published by Elsevier Masson SAS.
引用
收藏
页码:1190 / 1196
页数:7
相关论文
共 50 条
  • [21] Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor
    Tanaka, Ken
    Miyoshi, Hiroaki
    Kawamoto, Keisuke
    Shimasaki, Yasumasa
    Nakashima, Kazutaka
    Imamoto, Teppei
    Yamada, Kyohei
    Takeuchi, Mai
    Moritsubo, Mayuko
    Furuta, Takuya
    Kohno, Kei
    Tamura, Sinobu
    Sonoki, Takashi
    Ohshima, Koichi
    PATHOLOGY, 2024, 56 (01) : 81 - 91
  • [22] CD24 expression predicts poor prognosis for patients with cutaneous malignant melanoma
    Tang, Ming-Rui
    Wang, Yu-Xin
    Guo, Shu
    Han, Si-Yuan
    Li, He-Huan
    Jin, Shi-Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (11): : 4337 - 4341
  • [23] CD47 expression predicts efficacy of macrophage-mediated phagocytosis of tumor cells
    Yang, Huajun
    Li, Zhongliang
    Tang, Beibei
    Xing, Frank
    Shi, Qian
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [24] Correlated intrinsic breast cancer subtypes and expression of CD47 in BM predicts recurrence
    Nagahara, Makoto
    Sugihara, Kenichi
    Mori, Masaki
    CANCER RESEARCH, 2013, 73
  • [25] CD47 in the Immune Response: Role of Thrombospondin and SIRP-α Reverse Signaling
    Sarfati, Marika
    Fortin, Genevieve
    Raymond, Marianne
    Susin, Santos
    CURRENT DRUG TARGETS, 2008, 9 (10) : 842 - 850
  • [26] Ubiquitination of CD47 Regulates Innate Anti-Tumor Immune Response
    Gou, Qian
    Yan, Bingjun
    Duan, Yalan
    Guo, Yilei
    Qian, Jing
    Shi, Juanjuan
    Hou, Yongzhong
    ADVANCED SCIENCE, 2025, 12 (05)
  • [27] Evaluation of CD47 expression and effects of CD47-SIRPα fusion protein in patients with osteosarcoma
    Piperdi, Sajida
    Roth, Michael
    Morriss, Nick
    Zinone, Christian
    Zhang, Wendong
    Koirala, Pratistha
    Geller, David
    Hoang, Bang
    Yang, Rui
    Gill, Jonathan
    Garlick, Richard
    CANCER RESEARCH, 2016, 76
  • [28] Next Generation of Immune Targets: CD47 and CD70 Expression in Cutaneous Lesions
    Trindade, Christopher
    Agrawal, Tanupriya
    Tadros, Saber
    Fetsch, Patricia
    Ashford, TaShanda
    Ray-Chaudhury, Abhik
    Peters, Sara
    Filie, Armando
    Miettinen, Markku
    Hewitt, Stephen
    MODERN PATHOLOGY, 2019, 32
  • [29] Correlated Expression of CD47 and SIRPA in Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients
    Nagahara, Makoto
    Mimori, Koshi
    Kataoka, Akemi
    Ishii, Hideshi
    Tanaka, Fumiaki
    Nakagawa, Tsuyoshi
    Sato, Takanobu
    Ono, Shinji
    Sugihara, Kenichi
    Mori, Masaki
    CLINICAL CANCER RESEARCH, 2010, 16 (18) : 4625 - 4635
  • [30] Next Generation of Immune Targets: CD47 and CD70 Expression in Cutaneous Lesions
    Trindade, Christopher
    Agrawal, Tanupriya
    Tadros, Saber
    Fetsch, Patricia
    Ashford, TaShanda
    Ray-Chaudhury, Abhik
    Peters, Sara
    Filie, Armando
    Miettinen, Markku
    Hewitt, Stephen
    LABORATORY INVESTIGATION, 2019, 99